Cytiva Opens New Manufacturing Facility in Massachusetts
Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors.
Cytiva opened its new 80,000-ft2 manufacturing facility in Shrewsbury, MA, the company announced in a Dec. 21, 2020 press release. The new facility will make Xcellerex XDR single-use bioreactors and is part of Cytiva’s $500 million global capacity expansion planned for the next five years. The Shrewsbury site expansion was supported by a Technology Investment Agreement entered in October with the US Biomedical Advanced Research and Development Authority (BARDA).
The new facility was built in less than five months to meet demand for the company’s technologies. The building includes five manufacturing lines operating 24/5, a new cleanroom, and an R&D lab. The company is also adding manufacturing lines for complementary single-use technologies at its Westborough, MA facility and expects the capacity expansion to be completed by Q2 2021.
Source: Cytiva
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
